Cite

HARVARD Citation

    Vacirca, J. et al. (n.d.). An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer. Cancer medicine. pp. 1660-1669. [Online]. 
  
Back to record